EP3288539A4 - Flüssige retard-zusammensetzungen von metformin - Google Patents

Flüssige retard-zusammensetzungen von metformin Download PDF

Info

Publication number
EP3288539A4
EP3288539A4 EP16789379.1A EP16789379A EP3288539A4 EP 3288539 A4 EP3288539 A4 EP 3288539A4 EP 16789379 A EP16789379 A EP 16789379A EP 3288539 A4 EP3288539 A4 EP 3288539A4
Authority
EP
European Patent Office
Prior art keywords
metformin
extended release
liquid compositions
release liquid
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16789379.1A
Other languages
English (en)
French (fr)
Other versions
EP3288539A1 (de
Inventor
Romi Barat Singh
Ashish Kumar
Rajesh Srikrishan Shear
Satish Kumar Jain
Paras P. JAIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2015/053207 external-priority patent/WO2015166472A1/en
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of EP3288539A1 publication Critical patent/EP3288539A1/de
Publication of EP3288539A4 publication Critical patent/EP3288539A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP16789379.1A 2015-05-01 2016-05-02 Flüssige retard-zusammensetzungen von metformin Withdrawn EP3288539A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IB2015/053207 WO2015166472A1 (en) 2014-05-01 2015-05-01 Extended release liquid compositions of metformin
US15/133,773 US20160228360A1 (en) 2014-05-01 2016-04-20 Extended release liquid compositions of metformin
PCT/IB2016/052484 WO2016178130A1 (en) 2015-05-01 2016-05-02 Extended release liquid compositions of metformin

Publications (2)

Publication Number Publication Date
EP3288539A1 EP3288539A1 (de) 2018-03-07
EP3288539A4 true EP3288539A4 (de) 2019-07-10

Family

ID=57221629

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16789379.1A Withdrawn EP3288539A4 (de) 2015-05-01 2016-05-02 Flüssige retard-zusammensetzungen von metformin

Country Status (2)

Country Link
EP (1) EP3288539A4 (de)
WO (1) WO2016178130A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
JP2017524471A (ja) 2014-07-30 2017-08-31 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． 二重室の包装体
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015166473A1 (en) * 2014-05-01 2015-11-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6676966B1 (en) * 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
MXPA03001157A (es) * 2000-08-07 2004-02-17 Ranbaxy Signature Llc Formulacion liquida de metformina.
FR2816840B1 (fr) * 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
AU2003261298A1 (en) * 2002-08-02 2004-02-23 Penwest Pharmaceuticals Company Sustained release formulations of metformin
WO2007109104A2 (en) * 2006-03-16 2007-09-27 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015166473A1 (en) * 2014-05-01 2015-11-05 Sun Pharmaceutical Industries Limited Extended release suspension compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016178130A1 *

Also Published As

Publication number Publication date
EP3288539A1 (de) 2018-03-07
WO2016178130A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
PT3523390T (pt) Utilização de composições à base de tetrafluoropropeno
EP3137060A4 (de) Suspensionszusammensetzungen mit verlängerter freisetzung
EP3226839A4 (de) Gastroretentive suspensionszusammensetzungen mit verlängerter freisetzung
EP3240410A4 (de) Verwendung von picolinamiden als fungizide
EP3096759A4 (de) Formulierungen aus pridopidin mit modifizierter freisetzung
EP3102555A4 (de) Zusammensetzungen von verbindungen und verwendungen davon
EP3099381A4 (de) Duftstoffzusammensetzungen mit verlängerter freisetzung
EP3095829A4 (de) Haftmittelzusammensetzung
HK1257500A1 (zh) 包含尿石素化合物的組合物
EP3347333A4 (de) Verwendung von polymerisationshemmerzusammensetzungen
GB2528779B (en) Adhesive compositions
EP3116511A4 (de) Zusammensetzungen von selenoorganischen verbindungen und verfahren zur verwendung davon
SG10201602858XA (en) Antifouling Composition
EP3210613A4 (de) Zusammensetzung zur äusseren anwendung
EP3137057A4 (de) Pharmazeutische retard-zusammensetzungen von metformin
EP3221420A4 (de) Fotochrom-elektrochrome zusammensetzungen
EP3224321A4 (de) Wasserbasierte zusammensetzung
EP3384921A4 (de) Neue verwendung von thiopeptin
EP3302061A4 (de) Harnstoffzusammensetzungen mit verlängerter freisetzung
GB201507477D0 (en) Adhesive compositions
EP3384966A4 (de) Feuerlöschmittelzusammensetzung
EP3288539A4 (de) Flüssige retard-zusammensetzungen von metformin
ZA201700518B (en) Use of active compound compositions
PL3204459T3 (pl) Kompozycja powlekająca zawierająca środek przeciw kożuszeniu
EP3138569A4 (de) Zusammensetzung zur äusseren anwendung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171201

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

A4 Supplementary search report drawn up and despatched

Effective date: 20190514

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/10 20060101ALI20190508BHEP

Ipc: A61K 9/50 20060101ALI20190508BHEP

Ipc: C07C 279/26 20060101ALI20190508BHEP

Ipc: A61K 9/08 20060101ALI20190508BHEP

Ipc: A61K 31/155 20060101ALI20190508BHEP

Ipc: A61K 9/00 20060101AFI20190508BHEP

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20190611

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/08 20060101ALI20190604BHEP

Ipc: A61K 31/155 20060101ALI20190604BHEP

Ipc: A61K 9/50 20060101ALI20190604BHEP

Ipc: A61K 9/10 20060101ALI20190604BHEP

Ipc: A61K 9/00 20060101AFI20190604BHEP

Ipc: C07C 279/26 20060101ALI20190604BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191203